Enterprise Europe Network in Switzerland: HIV mouse models to develop new anti-HIV/AIDS therapies and other immune-related disease therapies

Selected Technology Offer

09 July 2012

HIV mouse models to develop new anti-HIV/AIDS therapies and other immune-related disease therapies

A Swiss company is looking for Research partners as well as sponsors to develop a new cure by engineering an HIV-resistant immune system

Abstract
A Swiss company provides access to humanized immune system (HIS) mice susceptible to human immune system (IS) diseases. It offers its technology to industrial and academic partners for preclinical development of therapeutic potential compounds against human IS diseases: infectious (HIV, Hepatitis C, etc), cancer, IS related. Advantages are cost-effectiveness, study time reduction and direct observation of human IS characteristics. Moreover, HIV mice model is the only alternative to monkey models.

Reference Nr 12 CH 84FB 3PPM

Detailed description

<- retour:

Technology e-Alerts

Receive the latest technologies matching your profile. Subscribe.

Promote your technology

You could not find a technology offer matching your needs. Create your own technology request to search a tailor made solution.

Brokerage Events

/ Show all

28 June 2013, Turin, Italy

TO Design 2013 Brokerage Event

20 June 2013, Dublin, Ireland

EuroNanoForum 2013

###LATEST_LINK###

Technology Requests

/ Show all

02 April 2013

Proven methods and devices that help babies sleep

20 March 2013

Looking for unmanned aircraft technologies to monitor crop productions and conduct fields surveys

###LATEST_LINK###

Enterprise Europe Network is funded by the European Commission, DG Enterprise and Industry via the Competitiveness and Innovation Programme (CIP).
Swiss network partners are financed by the Swiss government, Euresearch by the State Secretariat for Education, Research and Innovation (SERI),

Osec by the State Secretariat for Economic Affairs (SECO).